Most Recent Articles by Laura Entis
For one of President Trump's proposals for lowering the cost of drugs, the path to implementation could be long.
Feds join whistleblower case against Insys; Kleiner Perkins Caufield partner Seidenberg departs; Lilly strikes second acquisition deal in a week.
Beam Therapeutics raises $87 million in Series A funding; Trump drug-pricing plan largely spares big pharma; Novartis regrets Cohen consulting pact.
Thanks to legalization, a new breed of startups are changing the nature of cannabis advertising.
Takeda, Shire reach a deal; Walmart to restrict opioid prescriptions; Glaxo launches global media review.